Table 1.

Baseline Patient Characteristics and Prognostic Markers (N = 100)

Characteristic	Rituximab Plus Chlorambucil
Sex, %
Male	66
Female	34
Age, years
Median	70
Range	43-86
Binet stage, %
B	44
C	56
No. of comorbidities
Median	7
Range	0-20
IgVH mutation status, %
Mutated	36
Unmutated	52
Biclonal or test not performed	12
Cytogenetics, %
13q deletion	43
12q trisomy	16
11q deletion	13
17p deletion	3
No abnormalities or test not performed	37